Lexicon Pharmaceuticals
LXRX
#6643
Rank
โ‚น68.13 B
Marketcap
โ‚น160.82
Share price
-5.77%
Change (1 day)
193.90%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -โ‚น5.92 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น70.86 Million. In 2024 the company made an earning of -โ‚น18.8 Billion a decrease over its 2023 earnings that were of -โ‚น16.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น5.92 Billion-68.53%
2024 -โ‚น18.8 Billion13.15%
2023 -โ‚น16.61 Billion73.74%
2022 -โ‚น9.56 Billion16.16%
2021 -โ‚น8.23 Billion49.82%
2020 -โ‚น5.5 Billion-147.19%
2019 โ‚น11.63 B-203.42%
2018 -โ‚น11.26 Billion-15.31%
2017 -โ‚น13.29 Billion0.2%
2016 -โ‚น13.27 Billion2920.7%
2015 -โ‚น0.44 Billion-95.33%
2014 -โ‚น9.42 Billion-3.61%
2013 -โ‚น9.77 Billion-5.52%
2012 -โ‚น10.34 Billion-4.17%
2011 -โ‚น10.79 Billion15.5%
2010 -โ‚น9.34 Billion8.36%
2009 -โ‚น8.62 Billion-4.81%
2008 -โ‚น9.06 Billion28.79%
2007 -โ‚น7.03 Billion35.71%
2006 -โ‚น5.18 Billion52.91%
2005 -โ‚น3.39 Billion-23.89%
2004 -โ‚น4.45 Billion-24.19%
2003 -โ‚น5.87 Billion-0.48%
2002 -โ‚น5.9 Billion44.12%
2001 -โ‚น4.1 Billion23.01%
2000 -โ‚น3.33 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น685.30 B-10,756.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น111.21 B-1,829.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น490.50 B-7,727.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น47.74 Billion 642.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น15.34 B-338.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.58 Billion-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.18 Billion-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น45.24 B-803.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.89 Billion-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA